266 related articles for article (PubMed ID: 22545639)
21. Medication reconciliation for controlled substances--an "ideal" prescription-drug monitoring program.
Perrone J; Nelson LS
N Engl J Med; 2012 Jun; 366(25):2341-3. PubMed ID: 22646509
[No Abstract] [Full Text] [Related]
22. The relationship between source of diversion and prescription drug misuse, abuse, and dependence.
Ford JA; Lacerenza C
Subst Use Misuse; 2011; 46(6):819-27. PubMed ID: 21174499
[TBL] [Abstract][Full Text] [Related]
23. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed?
Peckham AM; Fairman KA; Sclar DA
Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090
[TBL] [Abstract][Full Text] [Related]
24. Windmills and pill mills: can PDMPs tilt the prescription drug epidemic?
Gugelmann H; Perrone J; Nelson L
J Med Toxicol; 2012 Dec; 8(4):378-86. PubMed ID: 23180357
[TBL] [Abstract][Full Text] [Related]
25. A qualitative analysis of prescribers' and dispensers' views on improving prescription drug monitoring programs.
Carnes NA; Wright ER; Norwood CW
Res Social Adm Pharm; 2017 Nov; 13(6):1167-1174. PubMed ID: 28007411
[TBL] [Abstract][Full Text] [Related]
26. Time-Series Analysis of the Impact of Prescription Drug Monitoring Programs on Heroin Treatment Admissions.
Branham DK
Subst Use Misuse; 2018 Mar; 53(4):694-701. PubMed ID: 28952830
[TBL] [Abstract][Full Text] [Related]
27. Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health.
Ali MM; Dowd WN; Classen T; Mutter R; Novak SP
Addict Behav; 2017 Jun; 69():65-77. PubMed ID: 28152391
[TBL] [Abstract][Full Text] [Related]
28. Prescription drug abuse: problem, policies, and implications.
Phillips J
Nurs Outlook; 2013; 61(2):78-84. PubMed ID: 23245611
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
[TBL] [Abstract][Full Text] [Related]
30. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.
Butler SF; Budman SH; Licari A; Cassidy TA; Lioy K; Dickinson J; Brownstein JS; Benneyan JC; Green TC; Katz N
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1142-54. PubMed ID: 18932173
[TBL] [Abstract][Full Text] [Related]
31. Prescription drug monitoring programs: Combating prescription drug misuse.
Gudoski AJ
Nurse Pract; 2015 Nov; 40(11):28-33; quiz 33-4. PubMed ID: 26474200
[TBL] [Abstract][Full Text] [Related]
32. Prescription drug abuse: an epidemic dilemma.
DuPont RL
J Psychoactive Drugs; 2010 Jun; 42(2):127-32. PubMed ID: 20648908
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Florida physicians' knowledge and attitudes toward accessing the state prescription drug monitoring program as a prescribing tool.
Gershman JA; Gershman JA; Fass AD; Popovici I
Pain Med; 2014 Dec; 15(12):2013-9. PubMed ID: 24931295
[TBL] [Abstract][Full Text] [Related]
34. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.
Norwood CW; Wright ER
Res Social Adm Pharm; 2016; 12(2):257-66. PubMed ID: 26143489
[TBL] [Abstract][Full Text] [Related]
35. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse.
Pauly V; Frauger E; Pradel V; Rouby F; Berbis J; Natali F; Reggio P; Coudert H; Micallef J; Thirion X
Drug Alcohol Depend; 2011 Jan; 113(1):29-36. PubMed ID: 20692778
[TBL] [Abstract][Full Text] [Related]
36. Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania.
Paulozzi LJ; Stier DD
J Public Health Policy; 2010 Dec; 31(4):422-32. PubMed ID: 21119649
[TBL] [Abstract][Full Text] [Related]
37. How does use of a prescription monitoring program change medical practice?
Green TC; Mann MR; Bowman SE; Zaller N; Soto X; Gadea J; Cordy C; Kelly P; Friedmann PD
Pain Med; 2012 Oct; 13(10):1314-23. PubMed ID: 22845339
[TBL] [Abstract][Full Text] [Related]
38. Prescription database: a new tool in drug fight.
Gadea J
Conn Med; 2010 Mar; 74(3):169-70. PubMed ID: 20391826
[No Abstract] [Full Text] [Related]
39. Assessment of doctor-shopping for high dosage buprenorphine maintenance treatment in a French region: development of a new method for prescription database.
Pradel V; Thirion X; Ronfle E; Masut A; Micallef J; Bégaud B
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):473-81. PubMed ID: 15269931
[TBL] [Abstract][Full Text] [Related]
40. Prescription-type drug misuse and workplace access among nurses.
Trinkoff AM; Storr CL; Wall MP
J Addict Dis; 1999; 18(1):9-17. PubMed ID: 10234559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
